Mechanisms that promote and suppress chromosomal translocations in lymphocytes.
暂无分享,去创建一个
[1] F. Alt,et al. ATM Damage Response and XLF Repair Factor are Functionally Redundant In Joining DNA Breaks , 2010, Nature.
[2] Robert S. Illingworth,et al. Immunostaining of modified histones defines high-level features of the human metaphase epigenome , 2010, Genome Biology.
[3] Michael M. Murphy,et al. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification , 2010, The Journal of experimental medicine.
[4] M. Lieber,et al. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. , 2010, Annual review of biochemistry.
[5] Guliang Wang,et al. Pathways for double-strand break repair in genetically unstable Z-DNA-forming sequences. , 2010, Journal of molecular biology.
[6] David G. Schatz,et al. The In Vivo Pattern of Binding of RAG1 and RAG2 to Antigen Receptor Loci , 2010, Cell.
[7] M. Lieber,et al. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not. , 2010, Blood.
[8] M. Nussenzweig,et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination , 2010, The Journal of experimental medicine.
[9] M. Nussenzweig,et al. Origin of Chromosomal Translocations in Lymphoid Cancer , 2010, Cell.
[10] R. Feil,et al. Genome-wide DNA demethylation in mammals , 2010, Genome Biology.
[11] Ryan Dale,et al. Cell type specificity of chromatin organization mediated by CTCF and cohesin , 2010, Proceedings of the National Academy of Sciences.
[12] F. Alt,et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4 , 2010, The Journal of experimental medicine.
[13] M. Lieber,et al. Mechanisms of chromosomal rearrangement in the human genome , 2010, BMC Genomics.
[14] F. Alt,et al. Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome , 2010, Proceedings of the National Academy of Sciences.
[15] D. Grimwade,et al. Molecular biology of therapy-related leukaemias , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[16] F. Alt,et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70 , 2010, Proceedings of the National Academy of Sciences.
[17] M. Nussenzweig,et al. Role of the translocation partner in protection against AID-dependent chromosomal translocations , 2009, Proceedings of the National Academy of Sciences.
[18] Jie Zhang,et al. Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer , 2009, Cell.
[19] Thomas Ried,et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. , 2009, Molecular cell.
[20] F. Alt,et al. Long-range Oncogenic Activation of IgH/c-myc Translocations by the IgH 3’ Regulatory Region , 2009, Nature.
[21] S. Kulkarni,et al. Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis , 2009, Proceedings of the National Academy of Sciences.
[22] F. Alt,et al. Mechanisms promoting translocations in editing and switching peripheral B cells , 2009, Nature.
[23] P. Fraser,et al. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus , 2009, Nature.
[24] M. Neuberger,et al. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence , 2009, Proceedings of the National Academy of Sciences.
[25] A. Miele,et al. Mechanisms that regulate localization of a DNA double-strand break to the nuclear periphery. , 2009, Genes & development.
[26] T. Misteli,et al. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma , 2009, Proceedings of the National Academy of Sciences.
[27] M. Lieber,et al. Conformational Variants of Duplex DNA Correlated with Cytosine-rich Chromosomal Fragile Sites* , 2009, Journal of Biological Chemistry.
[28] F. Alt,et al. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice , 2009, Proceedings of the National Academy of Sciences.
[29] F. Alt,et al. Chromosomal location targets different MYC family gene members for oncogenic translocations , 2009, Proceedings of the National Academy of Sciences.
[30] S. Pauklin,et al. Estrogen directly activates AID transcription and function , 2009, The Journal of experimental medicine.
[31] A. Feeney,et al. Cutting Edge: Developmental Stage-Specific Recruitment of Cohesin to CTCF Sites throughout Immunoglobulin Loci during B Lymphocyte Development1 , 2009, The Journal of Immunology.
[32] Michael M. Murphy,et al. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching , 2008, The Journal of experimental medicine.
[33] Kefei Yu,et al. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV–deficient B cells , 2008, The Journal of experimental medicine.
[34] B. Druker,et al. Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.
[35] M. Nussenzweig,et al. AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.
[36] M. Lieber,et al. Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity , 2008, Cell.
[37] S. Raghavan,et al. Chromosomal translocations in cancer. , 2008, Biochimica et biophysica acta.
[38] D. Spector,et al. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility , 2008, Nature.
[39] B. Chait,et al. Regulation of class switch recombination and somatic mutation by AID phosphorylation , 2008, The Journal of experimental medicine.
[40] Grant W. Brown,et al. Functional Targeting of DNA Damage to a Nuclear Pore-Associated SUMO-Dependent Ubiquitin Ligase , 2008, Science.
[41] M. Nussenzweig,et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination , 2008, Nature.
[42] M. Lavin,et al. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer , 2008, Nature Reviews Molecular Cell Biology.
[43] Michael M. Murphy,et al. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. , 2008, Molecular cell.
[44] F. Alt,et al. Complementary functions of ATM and H2AX in development and suppression of genomic instability , 2008, Proceedings of the National Academy of Sciences.
[45] Thomas Tuschl,et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.
[46] Michel C Nussenzweig,et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. , 2008, Immunity.
[47] K. Valerie,et al. Coordinate 5′ and 3′ endonucleolytic trimming of terminally blocked blunt DNA double-strand break ends by Artemis nuclease and DNA-dependent protein kinase , 2008, Nucleic acids research.
[48] Tobias A. Knoch,et al. The 3D Structure of the Immunoglobulin Heavy-Chain Locus: Implications for Long-Range Genomic Interactions , 2008, Cell.
[49] Job Dekker,et al. Gene Regulation in the Third Dimension , 2008, Science.
[50] J. Manis,et al. Fixing DNA breaks during class switch recombination , 2008, The Journal of experimental medicine.
[51] Michael M. Murphy,et al. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination , 2008, The Journal of experimental medicine.
[52] D. Schatz,et al. Two levels of protection for the B cell genome during somatic hypermutation , 2008, Nature.
[53] T. Golub,et al. Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas , 2008, Oncogene.
[54] J. Guirouilh-Barbat,et al. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends , 2007, Proceedings of the National Academy of Sciences.
[55] R. Schneider,et al. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. , 2007, Genes & development.
[56] Wei Yang,et al. The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2 , 2007, Proceedings of the National Academy of Sciences.
[57] F. Alt,et al. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. , 2007, Immunity.
[58] E. Pinaud,et al. The 3′ IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype1 , 2007, The Journal of Immunology.
[59] S. Desiderio,et al. A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. , 2007, Immunity.
[60] S. Janz,et al. In a model of immunoglobulin heavy‐chain (IGH)/MYC translocation, the Igh 3′ regulatory region induces MYC expression at the immature stage of B cell development , 2007, Genes, chromosomes & cancer.
[61] Michael M. Murphy,et al. IgH class switching and translocations use a robust non-classical end-joining pathway , 2007, Nature.
[62] Barbara Corneo,et al. Rag mutations reveal robust alternative end joining , 2007, Nature.
[63] M. Nussenzweig,et al. A role for AID in chromosome translocations between c-myc and the IgH variable region , 2007, The Journal of experimental medicine.
[64] M. Nussenzweig,et al. ATM Prevents the Persistence and Propagation of Chromosome Breaks in Lymphocytes , 2007, Cell.
[65] Cameron S. Osborne,et al. Myc Dynamically and Preferentially Relocates to a Transcription Factory Occupied by Igh , 2007, PLoS biology.
[66] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[67] Gaudenz Danuser,et al. Positional stability of single double-strand breaks in mammalian cells , 2007, Nature Cell Biology.
[68] A. Aguilera,et al. Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex , 2007, Proceedings of the National Academy of Sciences.
[69] F. Papavasiliou,et al. Regulation of AID expression in the immune response , 2007, The Journal of experimental medicine.
[70] G. Chu,et al. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends , 2007, Proceedings of the National Academy of Sciences.
[71] M. Gallardo,et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination , 2007, Nature.
[72] B. Johansson,et al. The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.
[73] Frederick W. Alt,et al. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells , 2007, Proceedings of the National Academy of Sciences.
[74] Tom Misteli,et al. Spatial genome organization in the formation of chromosomal translocations. , 2007, Seminars in cancer biology.
[75] Frederick W. Alt,et al. References and Notes Supporting Online Material Materials and Methods Figs. S1 to S3 Table S1 References Antibody Class Switching Mediated by Yeast Endonuclease–generated Dna Breaks , 2022 .
[76] M. Nussenzweig,et al. Enhanced intra‐switch region recombination during immunoglobulin class switch recombination in 53BP1–/– B cells , 2007, European journal of immunology.
[77] W. Hofmann,et al. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells , 2007, The Journal of experimental medicine.
[78] David Nemazee,et al. Receptor editing in lymphocyte development and central tolerance , 2006, Nature Reviews Immunology.
[79] F. Alt,et al. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. , 2006, DNA repair.
[80] J. Rowley,et al. Chromatin structural elements and chromosomal translocations in leukemia. , 2006, DNA repair.
[81] S. Janz,et al. Myc translocations in B cell and plasma cell neoplasms. , 2006, DNA repair.
[82] T. Glover,et al. Common fragile sites as targets for chromosome rearrangements. , 2006, DNA repair.
[83] N. Osheroff,et al. Topoisomerase II and the etiology of chromosomal translocations. , 2006, DNA repair.
[84] David G. Schatz,et al. Targeting of somatic hypermutation , 2006, Nature Reviews Immunology.
[85] T. Pandita,et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination , 2006, Nature.
[86] S. Jackson,et al. gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes. , 2006, DNA repair.
[87] Michael M. Murphy,et al. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[88] David Jung,et al. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. , 2006, Annual review of immunology.
[89] James G. McNally,et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks , 2006, The Journal of cell biology.
[90] Michel C. Nussenzweig,et al. Role of genomic instability and p53 in AID-induced c-myc–Igh translocations , 2006, Nature.
[91] Michael M. Murphy,et al. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[92] S. Jackson,et al. XLF Interacts with the XRCC4-DNA Ligase IV Complex to Promote DNA Nonhomologous End-Joining , 2006, Cell.
[93] A. Fischer,et al. Cernunnos, a Novel Nonhomologous End-Joining Factor, Is Mutated in Human Immunodeficiency with Microcephaly , 2006, Cell.
[94] Michael M. Murphy,et al. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. , 2006, Molecular cell.
[95] D. Weinstock,et al. A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. , 2006, Blood.
[96] T. Ried,et al. 53BP1 Cooperates with p53 and Functions as a Haploinsufficient Tumor Suppressor in Mice , 2005, Molecular and Cellular Biology.
[97] F. Alt,et al. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation , 2005, Nature.
[98] R. Gascoyne,et al. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2‐positive germinal center B‐cell lymphomas , 2005, Genes, chromosomes & cancer.
[99] M. Lieber,et al. Both V(D)J Coding Ends but Neither Signal End Can Recombine at the bcl-2 Major Breakpoint Region, and the Rejoining Is Ligase IV Dependent , 2005, Molecular and Cellular Biology.
[100] L. Boxer,et al. Regulatory Elements in the Immunoglobulin Heavy Chain Gene 3′-Enhancers Induce c-myc Deregulation and Lymphomagenesis in Murine B Cells* , 2005, Journal of Biological Chemistry.
[101] A. Gennery,et al. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells , 2005, The Journal of experimental medicine.
[102] F. Alt,et al. An evolutionarily conserved target motif for immunoglobulin class-switch recombination , 2004, Nature Immunology.
[103] David I. Smith,et al. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. , 2004, Cancer genetics and cytogenetics.
[104] M. Nussenzweig,et al. AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.
[105] F. Alt,et al. The role of the non‐homologous end‐joining pathway in lymphocyte development , 2004, Immunological reviews.
[106] F. Alt,et al. The cellular response to general and programmed DNA double strand breaks. , 2004, DNA repair.
[107] Tom Misteli,et al. Tissue-specific spatial organization of genomes , 2004, Genome Biology.
[108] C. Desmaze,et al. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. , 2004, Molecular cell.
[109] M. Lieber,et al. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex , 2004, Nature.
[110] F. Alt,et al. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[111] T. Imanishi‐Kari,et al. T cell-independent somatic hypermutation in murine B cells with an immature phenotype. , 2004, Immunity.
[112] J. Aten,et al. Dynamics of DNA Double-Strand Breaks Revealed by Clustering of Damaged Chromosome Domains , 2004, Science.
[113] F. Alt,et al. Impaired V(D)J Recombination and Lymphocyte Development in Core RAG1-expressing Mice , 2003, The Journal of experimental medicine.
[114] K. Basso,et al. Molecular Pathogenesis of Non-Hodgkin's Lymphoma: the Role of Bcl-6 , 2003, Leukemia & lymphoma.
[115] George Iliakis,et al. Biochemical evidence for Ku-independent backup pathways of NHEJ. , 2003, Nucleic acids research.
[116] F. Alt,et al. Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.
[117] T. Ried,et al. H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.
[118] K. Toellner,et al. Extrafollicular antibody responses , 2003, Immunological reviews.
[119] Tom Misteli,et al. Spatial proximity of translocation-prone gene loci in human lymphomas , 2003, Nature Genetics.
[120] R. Rothstein,et al. Cell Cycle-Regulated Centers of DNA Double-Strand Break Repair , 2003, Cell cycle.
[121] M. Lieber,et al. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells , 2003, Nature Immunology.
[122] F. Alt,et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme , 2003, Nature.
[123] D. Schatz,et al. Regulation of RAG1/RAG2‐mediated transposition by GTP and the C‐terminal region of RAG2 , 2003, The EMBO journal.
[124] Sheryl K Elkin,et al. The C‐terminal portion of RAG2 protects against transposition in vitro , 2003, The EMBO journal.
[125] Sheryl K Elkin,et al. Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[126] A. Nussenzweig,et al. DNA damage-induced G2–M checkpoint activation by histone H2AX and 53BP1 , 2002, Nature Cell Biology.
[127] P. Mckinnon,et al. DNA ligase IV suppresses medulloblastoma formation. , 2002, Cancer research.
[128] Thomas Ried,et al. Evidence for Replicative Repair of DNA Double-Strand Breaks Leading to Oncogenic Translocation and Gene Amplification , 2002, The Journal of experimental medicine.
[129] F. Alt,et al. Unrepaired DNA Breaks in p53-Deficient Cells Lead to Oncogenic Gene Amplification Subsequent to Translocations , 2002, Cell.
[130] S. Steinberg,et al. RAG-Mediated V(D)J Recombination Is Not Essential for Tumorigenesis in Atm-Deficient Mice , 2002, Molecular and Cellular Biology.
[131] Michel C. Nussenzweig,et al. Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.
[132] J. Hoeijmakers,et al. Different types of V(D)J recombination and end‐joining defects in DNA double‐strand break repair mutant mammalian cells , 2002, European journal of immunology.
[133] A. Barzilai,et al. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. , 2002, DNA repair.
[134] F. Alt,et al. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. , 2001, Molecular cell.
[135] R. Bataille,et al. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. , 2001, Blood.
[136] Riccardo Dalla-Favera,et al. Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.
[137] P. Jeggo,et al. Cellular and Biochemical Impact of a Mutation in DNA Ligase IV Conferring Clinical Radiosensitivity* , 2001, The Journal of Biological Chemistry.
[138] Gouri Nanjangud,et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas , 2001, Nature.
[139] J. Boultwood. Ataxia telangiectasia gene mutations in leukaemia and lymphoma , 2001, Journal of clinical pathology.
[140] L. Povirk,et al. Accurate in Vitro End Joining of a DNA Double Strand Break with Partially Cohesive 3′-Overhangs and 3′-Phosphoglycolate Termini , 2001, The Journal of Biological Chemistry.
[141] A. Fischer,et al. Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency , 2001, Cell.
[142] Huichen Wang,et al. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. , 2001, Nucleic acids research.
[143] T. Cremer,et al. Chromosome territories, nuclear architecture and gene regulation in mammalian cells , 2001, Nature Reviews Genetics.
[144] M. Nikiforova,et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. , 2000, Science.
[145] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[146] Elke Feldmann,et al. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining , 2000, Nucleic Acids Res..
[147] F. Alt,et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[148] P. L. Bergsagel,et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[149] D. Roth,et al. Double-strand break repair in Ku86- and XRCC4-deficient cells. , 1998, Nucleic acids research.
[150] P. Jeggo. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. , 1998, Radiation research.
[151] M. Gellert,et al. DNA Transposition by the RAG1 and RAG2 Proteins A Possible Source of Oncogenic Translocations , 1998, Cell.
[152] David G. Schatz,et al. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system , 1998, Nature.
[153] M. Qumsiyeh,et al. No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma , 1998, Molecular and Cellular Biology.
[154] M. Lagally,et al. In situ visualization of DNA double-strand break repair in human fibroblasts. , 1998, Science.
[155] B. Nevaldine,et al. The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. , 1997, Radiation research.
[156] S. Desiderio,et al. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. , 1996, Immunity.
[157] M. Jasin,et al. Ku80-deficient Cells Exhibit Excess Degradation of Extrachromosomal DNA* , 1996, The Journal of Biological Chemistry.
[158] A. Taylor,et al. Leukemia and lymphoma in ataxia telangiectasia. , 1996, Blood.
[159] D. Ramsden,et al. Initiation of V(D)J recombination in a cell-free system , 1995, Cell.
[160] F. Alt,et al. Impairment of V(D)J recombination in double-strand break repair mutants. , 1993, Science.
[161] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[162] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[163] D. Schatz,et al. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.
[164] David Baltimore,et al. The V(D)J recombination activating gene, RAG-1 , 1989, Cell.
[165] J. Sklar,et al. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia , 1989, The Journal of experimental medicine.
[166] Roberto Piva,et al. The anaplastic lymphoma kinase in the pathogenesis of cancer , 2008, Nature Reviews Cancer.
[167] H. Marusawa. Aberrant AID expression and human cancer development. , 2008, The international journal of biochemistry & cell biology.
[168] F. Alt,et al. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. , 2007, Advances in immunology.
[169] T. Honjo,et al. Role of AID in tumorigenesis. , 2007, Advances in immunology.
[170] L. Foroni,et al. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36). , 2005, Haematologica.
[171] J. Danska,et al. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. , 2003, Cancer cell.
[172] F. Alt,et al. Mechanism and control of class-switch recombination. , 2002, Trends in immunology.
[173] Tactggtat Agcctagatgtgtttaga,et al. J-mediated Translocations in Lymphoid Neoplasms : A Functional Assessment of Genomic Instability by Cryptic Sites , 2001 .
[174] D. Schatz,et al. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. , 2000, Annual review of immunology.
[175] A. Khamlichi,et al. The 3' IgH regulatory region: a complex structure in a search for a function. , 2000, Advances in immunology.
[176] K. Calame,et al. Transcriptional regulation during B cell development. , 1998, Annual review of immunology.